Maede Salehi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maede Salehi has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
Tahereh Molania
Department of Oral Medicine, Dental Research Center, Mazandaran University of Medical Sciences, Sari, Iran; Faculty of Dentistry, Mazandaran University of Medical Sciences, Sari, Iran
5 shared publicationsAbolfazl Hosseinnataj
Assistant Professor, Department of Biostatistics Faculty of Health, Mazandaran University of Medical Sciences Sari Iran
4 shared publicationsMahmood Moosazadeh
Gastrointestitional Cancer Research Center, Non-communicable Disease Institute, Mazandaran University of Medical Sciences, Sari, Iran
4 shared publicationsMajid Saeedi
Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
4 shared publicationsAnahita Lotfizadeh
Dentist, Sari, Iran
3 shared publicationsHodis Ehsani
Department of Periodontics, Dental Research Center, Faculty of Dentistry, Mazandaran University of Medical Sciences, Sari, Iran
3 shared publications
Latest Publications
- Open Access
- 19 August 2026
- Published by Wiley in Clinical and Experimental Dental Research
- Vol. 12  (4)
In Vitro Evaluation of the Antifungal Activity of Salvia Leriifolia Leaf Hydroalcoholic Extract Compared to Nystatin and Fluconazole Against Candida albicans
Objectives: With the rising incidence of fungal infections in recent years, Candida albicans has become the leading cause of oral fungal infections, ranging from superficial to systemic forms. The extensive use of antifungal medications has led to drug resistance and adverse effects, highlighting the growing need to explore medicinal plants. This study aimed to assess the antifungal activity of the hydroalcoholic extract of Salvia leriifolia leaves on laboratory strains of Candida albicans , comparing its effects with those of the standard antifungal drugs Nystatin and Fluconazole. Material and Methods: This experimental study used 20 confirmed Candida albicans isolates. Malt extract agar and RPMIâ1640 media were prepared according to standard protocols, and Salvia leriifolia extract was obtained via maceration. Fungal suspensions and stock solutions were prepared at defined concentrations, and MICs were determined using the microdilution broth method per CLSIâM27âA3 guidelines. Data were analyzed with SPSS. Results: Salvia leriifolia extract demonstrated antifungal activity against Candida albicans , with MIC values ranging from 500 to 1000 Âľg/mL and a geometric mean MIC of 901.3 Âľg/mL. In contrast, nystatin and fluconazole exhibited markedly lower MIC ranges (0.063â16 and 0.063â1 Âľg/mL, respectively) and geometric mean MICs of 0.297 and 0.308 Âľg/mL, respectively. Statistical analysis revealed significantly higher MIC values for the extract compared with both antifungal agents ( p < 0.001, effect size = 0.87), whereas no significant difference was observed between nystatin and fluconazole ( p = 0.638). Despite its lower potency, the extract showed moderate antifungal activity against Candida albicans . Conclusions: This study demonstrated that while the hydroalcoholic extract of Salvia leriifolia is less potent than nystatin and fluconazole, it is still capable of partially inhibiting the growth of Candida albicans . These results underscore the potential role of medicinal plants in the treatment of fungal infections, especially in cases involving drug resistance or undesirable side effects from conventional medications.
- 19 August 2026
- Published by Wiley in Clinical and Experimental Dental Research
- Vol. 12  (4)
Open AccessIn Vitro Evaluation of the Antifungal Activity of Salvia Leriifolia Leaf Hydroalcoholic Extract Compared to Nystatin and Fluconazole Against Candida albicans
Objectives: With the rising incidence of fungal infections in recent years, Candida albicans has become the leading cause of oral fungal infections, ranging from superficial to systemic forms. The extensive use of antifungal medications has led to drug resistance and adverse effects, highlighting the growing need to explore medicinal plants. This study aimed to assess the antifungal activity of the hydroalcoholic extract of Salvia leriifolia leaves on laboratory strains of Candida albicans , comparing its effects with those of the standard antifungal drugs Nystatin and Fluconazole. Material and Methods: This experimental study used 20 confirmed Candida albicans isolates. Malt extract agar and RPMIâ1640 media were prepared according to standard protocols, and Salvia leriifolia extract was obtained via maceration. Fungal suspensions and stock solutions were prepared at defined concentrations, and MICs were determined using the microdilution broth method per CLSIâM27âA3 guidelines. Data were analyzed with SPSS. Results: Salvia leriifolia extract demonstrated antifungal activity against Candida albicans , with MIC values ranging from 500 to 1000 Âľg/mL and a geometric mean MIC of 901.3 Âľg/mL. In contrast, nystatin and fluconazole exhibited markedly lower MIC ranges (0.063â16 and 0.063â1 Âľg/mL, respectively) and geometric mean MICs of 0.297 and 0.308 Âľg/mL, respectively. Statistical analysis revealed significantly higher MIC values for the extract compared with both antifungal agents ( p < 0.001, effect size = 0.87), whereas no significant difference was observed between nystatin and fluconazole ( p = 0.638). Despite its lower potency, the extract showed moderate antifungal activity against Candida albicans . Conclusions: This study demonstrated that while the hydroalcoholic extract of Salvia leriifolia is less potent than nystatin and fluconazole, it is still capable of partially inhibiting the growth of Candida albicans . These results underscore the potential role of medicinal plants in the treatment of fungal infections, especially in cases involving drug resistance or undesirable side effects from conventional medications.
- Open Access
- 7 October 2025
- Published by Taylor & Francis in Journal of Oral Microbiology
- Vol. 17  (1)
Antifungal efficacy of caffeic acid and nano-caffeic acid particles against candidiasis: an in vitro study
Candidiasis is the most common oral fungal infection. Several medications have been introduced to manage this infection. This study investigated the antifungal effect of caffeic acid and nano-caffeic acid. The size and particle dispersion index (PDI) of caffeic acid-containing niosome vesicles were measured after their production. The zeta potential was measured using a Zetasizer Nano ZS, and the amount of nano-caffeic acid released from the vesicles was measured. Candida isolates were cultured in Malt Extract Agar medium. Nystatin, fluconazole, caffeic acid and nano-caffeic acid were studied according to the Clinical and Laboratory Standards Institute (CLSI) protocol (M27-A3/S4), a broth microdilution test was performed, and the minimum inhibitory concentration (MIC) was determined. The data were analyzed using the MannâWhitney and KruskalâWallis tests. The optimal formulation had 100 mg Tween 60, 100 mg Span 60, 200 mg cholesterol, a size of 271.83 Âą 3.11 nm, a PDI of 0.21 Âą 0.02, a zeta potential of 5.58 Âą 0.47 mV and an encapsulation efficiency (EE%) of 42.34 Âą 4.34%. The size, absolute zeta potential and EE% increased significantly with increasing cholesterol content from zero to 200 mg (P < 0.05). Caffeic acid, nano-caffeic acid, carrier, fluconazole and nystatin had the lowest to highest antifungal activity, respectively. According to the MIC50 and MIC90 values, nystatin, fluconazole, carrier, nano-caffeic acid and caffeic acid had the highest to lowest inhibitory efficiency against Candida species, respectively.
- 7 October 2025
- Published by Taylor & Francis in Journal of Oral Microbiology
- Vol. 17  (1)
Open AccessAntifungal efficacy of caffeic acid and nano-caffeic acid particles against candidiasis: an in vitro study
Candidiasis is the most common oral fungal infection. Several medications have been introduced to manage this infection. This study investigated the antifungal effect of caffeic acid and nano-caffeic acid. The size and particle dispersion index (PDI) of caffeic acid-containing niosome vesicles were measured after their production. The zeta potential was measured using a Zetasizer Nano ZS, and the amount of nano-caffeic acid released from the vesicles was measured. Candida isolates were cultured in Malt Extract Agar medium. Nystatin, fluconazole, caffeic acid and nano-caffeic acid were studied according to the Clinical and Laboratory Standards Institute (CLSI) protocol (M27-A3/S4), a broth microdilution test was performed, and the minimum inhibitory concentration (MIC) was determined. The data were analyzed using the MannâWhitney and KruskalâWallis tests. The optimal formulation had 100 mg Tween 60, 100 mg Span 60, 200 mg cholesterol, a size of 271.83 Âą 3.11 nm, a PDI of 0.21 Âą 0.02, a zeta potential of 5.58 Âą 0.47 mV and an encapsulation efficiency (EE%) of 42.34 Âą 4.34%. The size, absolute zeta potential and EE% increased significantly with increasing cholesterol content from zero to 200 mg (P < 0.05). Caffeic acid, nano-caffeic acid, carrier, fluconazole and nystatin had the lowest to highest antifungal activity, respectively. According to the MIC50 and MIC90 values, nystatin, fluconazole, carrier, nano-caffeic acid and caffeic acid had the highest to lowest inhibitory efficiency against Candida species, respectively.
- Open Access
- 26 September 2025
- Published by Springer Nature in BMC Oral Health
- Vol. 25  (1) , 1-13
Antifungal efficacy of cinnamaldehyde and nano-cinnamaldehyde particles against candidiasis: an in-vitro study
Candidiasis is humansâ most common oral fungal infection and is a major opportunistic fungal infection with significant morbidity and mortality, particularly in immunocompromised patients, highlighting its clinical importance worldwide. This study investigated the antifungal effect of nystatin, fluconazole, cinnamaldehyde, and nano-cinnamaldehyde on candidiasis. In this in vitro study, nano-cinnamaldehyde formulations were prepared using span60, tween60, and cholesterol for fabrication of noisome vesicles by the ethanol injection technique. The optimum formulation (cinnosome 2) was prepared with 100 mg Span 60, 100 mg Tween 60, and 50 mg cholesterol with 5 ml of ethanol. The size and particle dispersion index (PDI) of nanoparticles were measured using Dynamic Light Scattering technique, the zeta potential was measured using Zetasizer Nano ZS, and the amount of nano-cinnamaldehyde release was measured using dialysis by USP2 dissolution device. Twenty Candida species isolates, including C. albicans, Pichia kudriavzevii, Nakaseomyces glabratus, and C. tropicalis, were obtained from clinical samples, cultured in malt extract agar medium, and fungal suspensions were prepared in RPMI medium. For antifungal evaluation, the broth microdilution test was performed, and the MIC was read after 24 h. Differences between groups were determined by Mann-Whitney and Kruskal-Wallis tests at a significance level of 0.05 via GraphPad Prism 6 and SPSS 22 software. Among the five niosomal formulations, the optimal nanoparticle showed a mean size of 228.75 Âą 2.38 nm, PDI of 0.24 Âą 0.01, zeta potential of -10.87 Âą 1.09 mV, and encapsulation efficiency (EE%) of 66.71 Âą 3.93%. The size of the nanoparticles varied from 137 to 297 nm among the formulations, and the particle size increased significantly with the amount of cholesterol. Nystatin, fluconazole and nano-cinnamaldehyde showed the best antifungal property with the lowest geometric mean (GM), 0.177 Âľg/mL, 0. 308 Âľg/mL and 0.554 Âľg/mL, respectively, followed by cinnamaldehyde (2.732 Âľg/mL) and carrier (2.828 Âľg/mL). According to the MIC50 and MIC90 values, it was found that nystatin, fluconazole, nano-cinnamaldehyde, cinnamaldehyde and carrier have the highest to the lowest antifungal property, respectively. Findings revealed that nano-cinnamaldehyde exhibited excellent antifungal activity against more than 65% of Candida isolates, indicating its promise as a potent alternative for managing oral candidiasis. Not applicable.
- 26 September 2025
- Published by Springer Nature in BMC Oral Health
- Vol. 25  (1) , 1-13
Open AccessAntifungal efficacy of cinnamaldehyde and nano-cinnamaldehyde particles against candidiasis: an in-vitro study
Candidiasis is humansâ most common oral fungal infection and is a major opportunistic fungal infection with significant morbidity and mortality, particularly in immunocompromised patients, highlighting its clinical importance worldwide. This study investigated the antifungal effect of nystatin, fluconazole, cinnamaldehyde, and nano-cinnamaldehyde on candidiasis. In this in vitro study, nano-cinnamaldehyde formulations were prepared using span60, tween60, and cholesterol for fabrication of noisome vesicles by the ethanol injection technique. The optimum formulation (cinnosome 2) was prepared with 100 mg Span 60, 100 mg Tween 60, and 50 mg cholesterol with 5 ml of ethanol. The size and particle dispersion index (PDI) of nanoparticles were measured using Dynamic Light Scattering technique, the zeta potential was measured using Zetasizer Nano ZS, and the amount of nano-cinnamaldehyde release was measured using dialysis by USP2 dissolution device. Twenty Candida species isolates, including C. albicans, Pichia kudriavzevii, Nakaseomyces glabratus, and C. tropicalis, were obtained from clinical samples, cultured in malt extract agar medium, and fungal suspensions were prepared in RPMI medium. For antifungal evaluation, the broth microdilution test was performed, and the MIC was read after 24 h. Differences between groups were determined by Mann-Whitney and Kruskal-Wallis tests at a significance level of 0.05 via GraphPad Prism 6 and SPSS 22 software. Among the five niosomal formulations, the optimal nanoparticle showed a mean size of 228.75 Âą 2.38 nm, PDI of 0.24 Âą 0.01, zeta potential of -10.87 Âą 1.09 mV, and encapsulation efficiency (EE%) of 66.71 Âą 3.93%. The size of the nanoparticles varied from 137 to 297 nm among the formulations, and the particle size increased significantly with the amount of cholesterol. Nystatin, fluconazole and nano-cinnamaldehyde showed the best antifungal property with the lowest geometric mean (GM), 0.177 Âľg/mL, 0. 308 Âľg/mL and 0.554 Âľg/mL, respectively, followed by cinnamaldehyde (2.732 Âľg/mL) and carrier (2.828 Âľg/mL). According to the MIC50 and MIC90 values, it was found that nystatin, fluconazole, nano-cinnamaldehyde, cinnamaldehyde and carrier have the highest to the lowest antifungal property, respectively. Findings revealed that nano-cinnamaldehyde exhibited excellent antifungal activity against more than 65% of Candida isolates, indicating its promise as a potent alternative for managing oral candidiasis. Not applicable.
- Open Access
- 1 September 2025
- Published by Wolters Kluwer Health in Dental Research Journal
- Vol. 22  (9) , 38
Comparison of the effects of Persica and protact mouthwash on gingival healing after crown lengthening surgery - A double-blinded randomized clinical trial
Background: Plaque control is one of the main issues after crown lengthening surgery. It is advised to use mouthwashes since mechanical plaque control is not possible due to the presence of the wound. Thus, the present study aims to compare the effectiveness of Persica and Protact mouthwash on gingival healing after crown lengthening surgery. Materials and Methods: In this double-blind clinical trial, 33 candidates were randomly divided into three groups (n = 11). The first group used 0.2% chlorhexidine (CHX) mouthwash; the second group used Persica mouthwash; and the third group used Protact mouthwash. Patients were followed for 14 days and changes in their plaque index (PI), gingival index (GI), stain index (SI), tongue taste, and color were recorded. Data were analyzed using SPSS V.22 using the KruskalâWallis, Wilcoxon, and Chi-square tests. The significance level was considered to be < 0.05. Results: The PI decreases significantly after 14 days in the CHX group (P = 0.011), however, this difference was not significant in the other two groups. Moreover, the GI and SI were not significantly different in any of the groups (P > 0.05). The changes in the tongue color and taste were only observed in the CHX group and patient dissatisfaction was higher in this group. Conclusion: CHX is the gold standard for patients who have undergone clinical crown lengthening surgery; nevertheless, considering its side effects and bad taste, Persica and Protact herbal mouthwashes can be used in more sensitive and uncooperative individuals.
- 1 September 2025
- Published by Wolters Kluwer Health in Dental Research Journal
- Vol. 22  (9) , 38
Open AccessComparison of the effects of Persica and protact mouthwash on gingival healing after crown lengthening surgery - A double-blinded randomized clinical trial
Background: Plaque control is one of the main issues after crown lengthening surgery. It is advised to use mouthwashes since mechanical plaque control is not possible due to the presence of the wound. Thus, the present study aims to compare the effectiveness of Persica and Protact mouthwash on gingival healing after crown lengthening surgery. Materials and Methods: In this double-blind clinical trial, 33 candidates were randomly divided into three groups (n = 11). The first group used 0.2% chlorhexidine (CHX) mouthwash; the second group used Persica mouthwash; and the third group used Protact mouthwash. Patients were followed for 14 days and changes in their plaque index (PI), gingival index (GI), stain index (SI), tongue taste, and color were recorded. Data were analyzed using SPSS V.22 using the KruskalâWallis, Wilcoxon, and Chi-square tests. The significance level was considered to be < 0.05. Results: The PI decreases significantly after 14 days in the CHX group (P = 0.011), however, this difference was not significant in the other two groups. Moreover, the GI and SI were not significantly different in any of the groups (P > 0.05). The changes in the tongue color and taste were only observed in the CHX group and patient dissatisfaction was higher in this group. Conclusion: CHX is the gold standard for patients who have undergone clinical crown lengthening surgery; nevertheless, considering its side effects and bad taste, Persica and Protact herbal mouthwashes can be used in more sensitive and uncooperative individuals.
- Open Access
- 1 January 2025
- Published by Wiley in International Journal of Dentistry
- Vol. 2025  (1) , 5339532
Oral HealthâRelated Quality of Life and Oral Health Indices in Patients With Opioid Use Disorder Undergoing Methadone Maintenance Treatment
Background: Addiction to opioids causes several adverse effects, one of the most important of which is oral side effects. However, oral health has a noticeable impact on the quality of life. The purpose of the present study is to investigate the indicators of oral health and oral healthârelated quality of life (OHRQoL) among patients with opioid use disorder to help treatment planning. Methods: A total of 425 people suffering opioid use disorder were selected from addiction treatment centers in Sari. After recording demographic data, the OHRQoL questionnaire (OHIP[oral health impact profile]â14) was administered as an interview. Then nine questions related to xerostomia were asked and were followed by an oral examination to measure indices, including SBI (sulcus bleeding index), GI (gingival index), PI (plaque index), and DMFT (decayed, missed, and filled teeth), and an unstimulated salivary flow rate (USFR) sample was collected for weight measurement to determine patientsâ hyposalivation. Variables were described using mean, standard deviation, and frequency. KolmogorovâSmirnov, independent t , and Pearsonâs correlation coefficient tests were used in this study. Multivariate linear regression was used to evaluate the factors related to the quality of life score of opioid users. Statistical analysis was performed by SPSS16 with a significance level of 0.05. Results: The correlation between age, ADDâOHIP, and USFR with xerostomia was statistically significant ( p < 0.05). GI, SBI, and DMFT indices in patients with hyposalivation (determined by measuring USFR) were lower than those without hyposalivation (determined by measuring USFR) and the differences were not statistically significant ( p > 0.05). The results of the linear regression model showed that gender, xerostomia, and DMFT are the main determinants of OHIP. Conclusion: Gender, xerostomia, and DMFT are the main determinants of OHIP. Oral health and compliance with oral hygiene in people with opioid use disorder is poor and affects their quality of life. Therefore, providing them proper access to oral health services is necessary.
- 1 January 2025
- Published by Wiley in International Journal of Dentistry
- Vol. 2025  (1) , 5339532
Open AccessOral HealthâRelated Quality of Life and Oral Health Indices in Patients With Opioid Use Disorder Undergoing Methadone Maintenance Treatment
Background: Addiction to opioids causes several adverse effects, one of the most important of which is oral side effects. However, oral health has a noticeable impact on the quality of life. The purpose of the present study is to investigate the indicators of oral health and oral healthârelated quality of life (OHRQoL) among patients with opioid use disorder to help treatment planning. Methods: A total of 425 people suffering opioid use disorder were selected from addiction treatment centers in Sari. After recording demographic data, the OHRQoL questionnaire (OHIP[oral health impact profile]â14) was administered as an interview. Then nine questions related to xerostomia were asked and were followed by an oral examination to measure indices, including SBI (sulcus bleeding index), GI (gingival index), PI (plaque index), and DMFT (decayed, missed, and filled teeth), and an unstimulated salivary flow rate (USFR) sample was collected for weight measurement to determine patientsâ hyposalivation. Variables were described using mean, standard deviation, and frequency. KolmogorovâSmirnov, independent t , and Pearsonâs correlation coefficient tests were used in this study. Multivariate linear regression was used to evaluate the factors related to the quality of life score of opioid users. Statistical analysis was performed by SPSS16 with a significance level of 0.05. Results: The correlation between age, ADDâOHIP, and USFR with xerostomia was statistically significant ( p < 0.05). GI, SBI, and DMFT indices in patients with hyposalivation (determined by measuring USFR) were lower than those without hyposalivation (determined by measuring USFR) and the differences were not statistically significant ( p > 0.05). The results of the linear regression model showed that gender, xerostomia, and DMFT are the main determinants of OHIP. Conclusion: Gender, xerostomia, and DMFT are the main determinants of OHIP. Oral health and compliance with oral hygiene in people with opioid use disorder is poor and affects their quality of life. Therefore, providing them proper access to oral health services is necessary.
- Open Access
- 13 May 2023
- Published by Springer Nature in BMC Oral Health
- Vol. 23  (1) , 1-8
Atorvastatin mucoadhesive tablets in the management of recurrent aphthous stomatitis: a randomized clinical study
Background: Aphthous stomatitis is one of the most common oral mucosal diseases. Due to the commonness of recurrent aphthous stomatitis and considering the anti-inflammatory, analgesic, and tissue regenerative properties of atorvastatin and the lack of a study on the effect of statins on minor recurrent aphthous stomatitis, this study investigates the effect of atorvastatin mucoadhesive tablets as a topical treatment on reduction of symptoms and duration of this disease. Methods: This study is a randomized, double-blinded clinical trial. Patients were divided into two groups, atorvastatin and, placebo; each of the patients received three mucoadhesive tablets daily in the morning, noon, and night. Finally, the patients were examined on days 0 (baseline), 3, 5, and 7 to determine the diameter of the inflammatory halo. The VAS scale was used to evaluate pain intensity for up to 7 days after each meal. The data was entered into SPSS 24 software and analyzed. Results: The halo diameter did not significantly differ between the two groups on baseline (P > 0.05). However, on the studyâs third, fifth, and seventh days, the difference between the two groups was remarkable, so in the atorvastatin group, the size of the lesions decreased in shorter healing time (P < 0.05). In addition, the patientâs pain intensity (VAS) also showed a significant decrease in the atorvastatin group except on the first, second, and seventh days of the study (P < 0.05). Conclusion: Atorvastatin mucoadhesive tablets effectively reduce the pain of patients with minor recurrent aphthous stomatitis and reduce the size and healing time of the lesions, so their application should be considered in treating minor recurrent aphthous stomatitis. The present study was approved by the Medical Ethics Committee of Mazandaran University of Medical Sciences with the ethics code IR.MAZUMS.REC.1400.8346. Also, this study received code IRCT20170430033722N4.
- 13 May 2023
- Published by Springer Nature in BMC Oral Health
- Vol. 23  (1) , 1-8
Open AccessAtorvastatin mucoadhesive tablets in the management of recurrent aphthous stomatitis: a randomized clinical study
Background: Aphthous stomatitis is one of the most common oral mucosal diseases. Due to the commonness of recurrent aphthous stomatitis and considering the anti-inflammatory, analgesic, and tissue regenerative properties of atorvastatin and the lack of a study on the effect of statins on minor recurrent aphthous stomatitis, this study investigates the effect of atorvastatin mucoadhesive tablets as a topical treatment on reduction of symptoms and duration of this disease. Methods: This study is a randomized, double-blinded clinical trial. Patients were divided into two groups, atorvastatin and, placebo; each of the patients received three mucoadhesive tablets daily in the morning, noon, and night. Finally, the patients were examined on days 0 (baseline), 3, 5, and 7 to determine the diameter of the inflammatory halo. The VAS scale was used to evaluate pain intensity for up to 7 days after each meal. The data was entered into SPSS 24 software and analyzed. Results: The halo diameter did not significantly differ between the two groups on baseline (P > 0.05). However, on the studyâs third, fifth, and seventh days, the difference between the two groups was remarkable, so in the atorvastatin group, the size of the lesions decreased in shorter healing time (P < 0.05). In addition, the patientâs pain intensity (VAS) also showed a significant decrease in the atorvastatin group except on the first, second, and seventh days of the study (P < 0.05). Conclusion: Atorvastatin mucoadhesive tablets effectively reduce the pain of patients with minor recurrent aphthous stomatitis and reduce the size and healing time of the lesions, so their application should be considered in treating minor recurrent aphthous stomatitis. The present study was approved by the Medical Ethics Committee of Mazandaran University of Medical Sciences with the ethics code IR.MAZUMS.REC.1400.8346. Also, this study received code IRCT20170430033722N4.
- Open Access
- 31 March 2023
- Published by Wroclaw Medical University in Dental and Medical Problems
- Vol. 60  (1) , 99-107
Comparison of periodontal indices, DMFT, xerostomia, hyposalivation and oral health-related quality of life in SjĂśgrenâs syndrome patients versus healthy individuals: A caseâcontrol study
SjĂśgren's syndrome (SS) is a common systemic autoimmune disease that affects oral health, and consequently oral health-related quality of life (OHRQoL) due to the involvement of exocrine glands. The present study aimed to evaluate the oral health-related quality of life and oral health indicators in patients with SS in comparison with healthy individuals. In the case and control groups (45 patients and 45 healthy individuals), questions about demographic data, other systemic disorders, medications, the years of infection, xerostomia, as well as inquiries about the quality of life (Oral Health Impact Profile-14 - OHIP-14) were asked. The patients were evaluated clinically, and oral health indicators, including the plaque index (PI), the gingival index (GI), the sulcus bleeding index (SBI), and the number of decayed, missing and filled teeth (DMFT) were assessed on the Ramfjord teeth. Unstimulated saliva samples from both groups were obtained and weighed. The data was analyzed using IBM SPSS Statistics for Windows, v. 24.0. Quantitative variables were compared between the case and control groups with the use of the independent t test or their nonparametric equivalent (the Mann-Whitney test). The comparison of the quantitative variables between the study groups showed a statistically significant difference in the OHRQoL scores (p = 0.037) and the unstimulated saliva flow rate (p = 0.002) between the case and control groups. Also, there was a statistically significant difference in the DMFT index between patients with primary and secondary SS in the case group (p = 0.048). The lower OHRQoL of patients with SS requires more attention and follow-up to solve periodontal and dental problems in this group of patients.
- 31 March 2023
- Published by Wroclaw Medical University in Dental and Medical Problems
- Vol. 60  (1) , 99-107
Open AccessComparison of periodontal indices, DMFT, xerostomia, hyposalivation and oral health-related quality of life in SjĂśgrenâs syndrome patients versus healthy individuals: A caseâcontrol study
SjĂśgren's syndrome (SS) is a common systemic autoimmune disease that affects oral health, and consequently oral health-related quality of life (OHRQoL) due to the involvement of exocrine glands. The present study aimed to evaluate the oral health-related quality of life and oral health indicators in patients with SS in comparison with healthy individuals. In the case and control groups (45 patients and 45 healthy individuals), questions about demographic data, other systemic disorders, medications, the years of infection, xerostomia, as well as inquiries about the quality of life (Oral Health Impact Profile-14 - OHIP-14) were asked. The patients were evaluated clinically, and oral health indicators, including the plaque index (PI), the gingival index (GI), the sulcus bleeding index (SBI), and the number of decayed, missing and filled teeth (DMFT) were assessed on the Ramfjord teeth. Unstimulated saliva samples from both groups were obtained and weighed. The data was analyzed using IBM SPSS Statistics for Windows, v. 24.0. Quantitative variables were compared between the case and control groups with the use of the independent t test or their nonparametric equivalent (the Mann-Whitney test). The comparison of the quantitative variables between the study groups showed a statistically significant difference in the OHRQoL scores (p = 0.037) and the unstimulated saliva flow rate (p = 0.002) between the case and control groups. Also, there was a statistically significant difference in the DMFT index between patients with primary and secondary SS in the case group (p = 0.048). The lower OHRQoL of patients with SS requires more attention and follow-up to solve periodontal and dental problems in this group of patients.
- Open Access
- 14 June 2022
- Published by Springer Nature in BMC Oral Health
- Vol. 22  (1) , 1-7
Evaluation of cinnamaldehyde mucoadhesive patches on minor recurrent aphthous stomatitis: a randomized, double-blind, placebo-controlled clinical trial
Background & objective: The use of herbal medicines to treat common oral diseases increases rapidly. Recurrent aphthous stomatitis is one of the most common oral mucosal diseases, which has an unclear etiology and could lead to severe pain and dysfunction. Cinnamaldehyde is a major component of cinnamon bark oil. Biological properties of cinnamaldehyde, such as antioxidant, antitumor, antifungal, cytotoxic, and anti-mutational characteristics, have been identified. Considering the prevalence of recurrent aphthous stomatitis and the importance of using herbal resources for treatment, the present study aimed to evaluate the effect of mucosal adhesive patches containing Cinnamaldehyde on minor recurrent aphthous stomatitis lesions. Material & methods: In this randomized, double-blind clinical trial, patients were divided into two groups. The intervention group received three daily mucosal adhesive patches to be used in the morning, afternoon, and night. The control group also did the same with a placebo. To evaluate the healing and determine the diameter of the lesions, patients were clinically examined on days zero, 3, 5, and 7. The VAS scale evaluated pain at baseline and after each meal for seven days. The Fisher's exact test, t-test, Shapiro Wilk test, Friedman test, and the MannâWhitney test were used to analyze the data using the SPSS 20 software. Results: There was no statistically significant difference in the mean diameter of the inflammatory lesion and pain intensity in the two groups in the baseline (p > 0.05). However, the ulcer size was significantly reduced in the cinnamaldehyde group on the third, fifth, and seventh days of the study. Except for baseline, the mean pain intensity significantly decreased in the cinnamaldehyde group compared to the placebo group (p < 0.05). Conclusion: Cinnamaldehyde mucoadhesive patches effectively reduced and improved aphthous lesions and pain intensity in patients and can be considered a treatment for RAS. Registration number: IRCT20180312039060N2âFirst registration date: 20/07/2018. The present study was registered as a retrospective study.
- 14 June 2022
- Published by Springer Nature in BMC Oral Health
- Vol. 22  (1) , 1-7
Open AccessEvaluation of cinnamaldehyde mucoadhesive patches on minor recurrent aphthous stomatitis: a randomized, double-blind, placebo-controlled clinical trial
Background & objective: The use of herbal medicines to treat common oral diseases increases rapidly. Recurrent aphthous stomatitis is one of the most common oral mucosal diseases, which has an unclear etiology and could lead to severe pain and dysfunction. Cinnamaldehyde is a major component of cinnamon bark oil. Biological properties of cinnamaldehyde, such as antioxidant, antitumor, antifungal, cytotoxic, and anti-mutational characteristics, have been identified. Considering the prevalence of recurrent aphthous stomatitis and the importance of using herbal resources for treatment, the present study aimed to evaluate the effect of mucosal adhesive patches containing Cinnamaldehyde on minor recurrent aphthous stomatitis lesions. Material & methods: In this randomized, double-blind clinical trial, patients were divided into two groups. The intervention group received three daily mucosal adhesive patches to be used in the morning, afternoon, and night. The control group also did the same with a placebo. To evaluate the healing and determine the diameter of the lesions, patients were clinically examined on days zero, 3, 5, and 7. The VAS scale evaluated pain at baseline and after each meal for seven days. The Fisher's exact test, t-test, Shapiro Wilk test, Friedman test, and the MannâWhitney test were used to analyze the data using the SPSS 20 software. Results: There was no statistically significant difference in the mean diameter of the inflammatory lesion and pain intensity in the two groups in the baseline (p > 0.05). However, the ulcer size was significantly reduced in the cinnamaldehyde group on the third, fifth, and seventh days of the study. Except for baseline, the mean pain intensity significantly decreased in the cinnamaldehyde group compared to the placebo group (p < 0.05). Conclusion: Cinnamaldehyde mucoadhesive patches effectively reduced and improved aphthous lesions and pain intensity in patients and can be considered a treatment for RAS. Registration number: IRCT20180312039060N2âFirst registration date: 20/07/2018. The present study was registered as a retrospective study.
- 1 September 2021
- Vol. 9  (9) , 14341-14347
Prevalence of Molar Incisor Hypomineralisation among School Children of Sari, Iran
- 1 September 2021
- Vol. 9  (9) , 14341-14347
Prevalence of Molar Incisor Hypomineralisation among School Children of Sari, Iran